[{"from": "human", "value": "Provide a description of this molecule. [C][C][C][C][Branch1][Ring2][C][Ring1][Branch1][C][C][N][Branch2][Ring1][C][C][C][Ring1][#Branch1][C][N][Branch1][Ring2][C][Ring1][Branch2][C][C][C][C][Ring1][Ring1][C][C][C][C][Ring1][Ring1]"}, {"from": "gpt", "value": "The molecule is a member of the class of diazabicyclononanes that is (1s,5s)-3,7-diazaspiro[bicyclo[3.3.1]nonane-9,1'-cyclopentane] in which the hydrogens at positions 3 and 7 are replaced by cyclopropylmethyl groups. It is a potassium channel blocker and an antiarrhythmic agent currently currently in development for the treatment of atrial fibrillation. It has a role as an anti-arrhythmia drug and a potassium channel blocker. It is an azaspiro compound, a member of cyclopropanes, a member of cyclopentanes and a diazabicyclononane."}]